EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

Basit Öğe Kaydı
dc.contributor.authorGumus, Mahmut
dc.contributor.authorGeredeli, Caglayan
dc.contributor.authorUcar, Mahmut
dc.contributor.authorKaya, Serap
dc.contributor.authorDemir, Hacer
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorDegirmenci, Mustafa
dc.contributor.authorDogu, Gamze Gokoz
dc.contributor.authorTuran, Nedim
dc.contributor.authorYildirim, Nilgun
dc.contributor.authorBasal, Fatma Bugdayci
dc.contributor.authorArpaci, Erkan
dc.contributor.authorKaraagac, Mustafa
dc.contributor.authorHarputluoglu, Hakan
dc.contributor.authorTurk, Had Mehmet
dc.contributor.authorDane, Faysal
dc.contributor.authorOzkan, Metin
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T09:41:15Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T09:41:15Z
dc.date.issued2017
dc.departmentIstanbul Medeniyet Univ Hosp, Dept Med Oncol, Istanbul, Turkey -- Okmeydani Training & Res Hosp, Dept Med Oncol, Istanbul, Turkey -- Erciyes Univ, Dept Med Oncol, Kayseri, Turkey -- Marmara Univ, Med Oncol, Istanbul, Turkey -- Gazi Univ, Fac Med, Med Oncol Clin, Ankara, Turkey -- Ataturk Training & Res Hosp, Izmir, Turkey -- Tepecik Educ & Res Hosp, Izmir, Turkey -- Pamukkale Univ, Denizli, Turkey -- Cumhuriyet Univ, Sch Med, Dept Med Oncol, Sivas, Turkey -- Ataturk Univ, Dept Med Oncol, Erzurum, Turkey -- Ankara Numone Training & Res Hosp, Dept Med Oncol, Ankara, Turkey -- Bulent Ecevit Univ, Zonguldak, Turkey -- Konya Necmeddin Erbakan Univ, Meram Sch Med, Diyarbakir, Turkey -- Inonu Univ, Dept Med Oncol, Fac Med, Malatya, Turkey -- Bezmialem Univ, Med Oncol, Istanbul, Turkey -- Erciyes Univ, Dept Med Oncol, Kayseri, Turkeyen_US
dc.description53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, ILen_US
dc.description.abstract…en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e15028en_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.urihttps://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e15028
dc.identifier.urihttps://hdl.handle.net/20.500.12418/6782
dc.identifier.volume35en_US
dc.identifier.wosWOS:000411895707135en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAMER SOC CLINICAL ONCOLOGYen_US
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGYen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu